Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus
- PMID: 19479699
- PMCID: PMC2763591
- DOI: 10.1002/art.24519
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus
Abstract
Objective: To examine the lifetime prevalence of mood and anxiety disorders in patients with systemic lupus erythematosus (SLE). Demographic and disease-related variables were examined for association with lifetime major depressive disorder (MDD) and the presence of any mood or anxiety disorder.
Methods: Three hundred twenty-six white women with SLE completed the Composite International Diagnostic Interview and the Systemic Lupus Activity Questionnaire, a self-report measure of SLE disease activity. The binomial test was used to compare the prevalence of psychiatric diagnoses in patients with SLE with a population sample of white women.
Results: Sixty-five percent of the participants received a lifetime mood or anxiety diagnosis. MDD (47%), specific phobia (24%), panic disorder (16%), obsessive-compulsive disorder (9%), and bipolar I disorder (6%) were more common among patients with SLE than among other white women (P = 0.00009 for specific phobia; for all other values P = 0.00001). Although most patients with histories of mood disorders reported their psychiatric symptoms to a medical provider, a substantial number of patients with anxiety disorders did not. Self-reported disease activity was associated with a lifetime history of MDD (P = 0.001) and presence of a mood or anxiety disorder (P = 0.001), after controlling for demographic and clinical characteristics.
Conclusion: Several mood and anxiety disorders were more common in women with SLE compared with the general population, and disease activity may contribute to this higher risk. Brief self-report questionnaires may help providers identify patients with these conditions, particularly when patients are reluctant to disclose their symptoms.
References
-
- Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine. 2003;82:299–308. - PubMed
-
- Kozora E, Ellison MC, West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): Relationship to the American College of Rheumatology SLE Neuropsychological Battery. Arthritis Rheum. 2006;55:628–35. - PubMed
-
- Magner MB. Psychiatric morbidity in outpatients with systemic lupus erythematosus. SAMJ. 1990;80:291–3. - PubMed
-
- Miguel EC, Pereira RM, Pereira CA, Baer L, Gomes RE, de Sa LC, et al. Psychiatric manifestations of systemic lupus erythematosus: Clinical features, symptoms, and signs of central nervous system activity in 43 patients. Medicine. 1994;73:224–32. - PubMed
-
- Nery FG, Borba EF, Viana VST, Hatch JP, Soares JC, Bonfa E, et al. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Prog Neuropsychopharm Biol Psych. 2008;32:695–700. - PubMed